Health
Jonathan Wall receives $1.79 million to develop new amyloidosis treatment – EurekAlert
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science…
IMAGE: Dr. Jonathan Wall
view more
Credit: UTHSC
Memphis, Tenn. (March 16, 2021) – The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.”
Amyloidosis is a rare disease that occurs when abnormal protein aggregates (called amyloid)…
-
Noosa News22 hours agoThe Pedro Pascal-Led Fantastic Four Face Julia Garner’s Silver Surfer in the New Full ‘First Steps’ Trailer
-
General21 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
General22 hours agoPolice say man shot dead in Footscray had charged at officers armed with knife
-
General19 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?